Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22Neoplasms 20Leukemia, Myeloid, Acute 10Ovarian Neoplasms 8Neoplasm Metastasis 7Lymphoma 7Lung Neoplasms 7Hematologic Neoplasms 6Glioblastoma 6Colorectal Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leukemia 5Fatigue 5Stomach Neoplasms 4Depression 4Carcinoma, Non-Small-Cell Lung 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Myelodysplastic Syndromes 3Motor Activity 3Melanoma 3Fallopian Tube Neoplasms 3Carcinoma, Hepatocellular 3

Interventions

endostar protein 1coenzyme Q10 1apatinib 1Yoga 1Ubiquinone 1Tamoxifen 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Palliative Care 1Oxaliplatin 1Melatonin 1Gardening 1Fentanyl 1Exercise 1Educational Status 1Diet Therapy 1Chemoradiotherapy 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Quality of Life × Palliative Care × Clear all
NCT02311465 2015-12-11

A Randomized Study of Early Palliative Care

Vanderbilt University

Phase NA Withdrawn

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon âš¡